Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds
Status:
Terminated
Trial end date:
2020-08-30
Target enrollment:
Participant gender:
Summary
To create a protocol for treatment of Pakistani patients with SARS-CoV-2 infection with an
intent to reduce burden on institutional healthcare services by determining efficacy of
different quinone drug dosing regimens in controlling SARS-CoV-2 infection for asymptomatic
patients.
Phase:
Phase 4
Details
Lead Sponsor:
Government of Punjab, Specialized Healthcare and Medical Education Department
Collaborators:
Forman Christian College Forman Christian College, Pakistan Harvard School of Public Health Harvard School of Public Health (HSPH) Mayo Hospital Lahore Pakistan Kidney and Liver Institute Services Institute of Medical Sciences, Pakistan